Does diffusion-weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd-EOB-DTPA with and without DWI.
about
The Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imaging BiomarkersDiffusion magnetic resonance imaging: A molecular imaging tool caught between hope, hype and the real world of "personalized oncology"MR comparative study of combined hepatocellular-cholangiocarcinoma in normal, fibrotic, and cirrhotic livers.
P2860
Does diffusion-weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd-EOB-DTPA with and without DWI.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Does diffusion-weighted imagin ...... EOB-DTPA with and without DWI.
@en
Does diffusion-weighted imagin ...... EOB-DTPA with and without DWI.
@nl
type
label
Does diffusion-weighted imagin ...... EOB-DTPA with and without DWI.
@en
Does diffusion-weighted imagin ...... EOB-DTPA with and without DWI.
@nl
prefLabel
Does diffusion-weighted imagin ...... EOB-DTPA with and without DWI.
@en
Does diffusion-weighted imagin ...... EOB-DTPA with and without DWI.
@nl
P2093
P2860
P356
P1476
Does diffusion-weighted imagin ...... EOB-DTPA with and without DWI.
@en
P2093
Alexander Dechêne
Gerald Antoch
Juliane Schelhorn
Marcus P Reinboldt
Marcus Ruhlmann
Sonja Kinner
Thomas C Lauenstein
P2860
P304
P356
10.1002/JMRI.24827
P50
P577
2014-12-17T00:00:00Z